Literature DB >> 507137

Rewiew of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute.

J P Smith, T G Day.   

Abstract

The records of 2,115 patients with ovarian cancer who were treated at the M.D. Anderson Hospital and Tumor Institute in Houston, Texas, during the 30 year period from 1944 to 1973 were reviewed. Ninety percent of the patients had an epithelial cancer of the ovary. The important prognostic factors include stage and grade of tumor and the presence or absence of ascites. Probably the most important prognostic factor, however, was the size of the largest tumor mass that remained after initial surgery. The patient's age and socioeconomic level were also influencing factors in the survival rate in this series of patients. Most of the patients had advanced disease when first examined and received some type of adjunctive postoperative treatment. The survival of patients who received postoperative irradiation, when compared by stage and size of the largest residual tumor mass, was improved over those who received chemotherapy.

Entities:  

Mesh:

Year:  1979        PMID: 507137     DOI: 10.1016/0002-9378(79)90824-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Surgical procedures for ovarian cancer.

Authors:  J H Shepherd; M E Crowther; B G Ward; P Singh
Journal:  Ann R Coll Surg Engl       Date:  1986-11       Impact factor: 1.891

Review 2.  Current drug treatment guidelines for epithelial ovarian cancer.

Authors:  P C Lorigan; T Crosby; R E Coleman
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  [Surgical therapy of ovarian cancer].

Authors:  A Pfleiderer
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

Review 4.  Chemotherapy in advanced ovarian cancer.

Authors:  C J Rodenburg; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 5.  Non-uterine gynecological sarcomas.

Authors:  G Leppien
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

6.  Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.

Authors:  Mishka Terplan; Sarah Temkin; Ana Tergas; Ernst Lengyel
Journal:  Gynecol Oncol       Date:  2008-09-26       Impact factor: 5.482

7.  Diagnosis and staging of ovarian cancer.

Authors:  A Pfleiderer
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  Long-term survival in stage III and IV ovarian cancer.

Authors:  E Petru; B U Sevin; H E Averette; O R Koechli; S Hilsenbeck
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

9.  A study of the treatment of ovarian carcinoma.

Authors:  H Pickel
Journal:  Arch Gynecol       Date:  1983

10.  Optimal chemotherapy for ovarian carcinoma: discussion paper.

Authors:  H E Lambert
Journal:  J R Soc Med       Date:  1984-01       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.